ABIOMED Financial Statements
ABIOMED Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
ABIOMED Income Statement
| 2008# | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 58.9 | 50.7 | 43.7 |
| Gross Profit ($ mil.) | 43.9 | 38.6 | 32.0 |
| Operating Income ($ mil.) | (36.5) | (28.5) | (30.3) |
| Total Net Income ($ mil.) | (40.9) | (27.9) | (29.5) |
| Diluted EPS (Net Income) | (1.26) | (1.03) | (1.15) |
- # Fiscal year-end changed since last report from March to December
ABIOMED Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 17.5 | 16.0 | 11.4 |
| Gross Profit ($ mil.) | 12.6 | 12.3 | 8.5 |
| Operating Income ($ mil.) | (8.9) | (8.6) | (10.0) |
| Total Net Income ($ mil.) | (15.0) | (8.3) | (9.4) |
| Diluted EPS (Net Income) | (0.46) | (0.25) | (0.29) |
ABIOMED Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 10.13 | 2.11 | 1.53 |
| Price/Earnings Ratio | -- | 20.61 | 15.12 |
| Price/Book Ratio | 6.38 | 2.10 | 1.46 |
| Price/Cash Flow Ratio | -- | 15.31 | 9.52 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed ABIOMED Financial Ratios
ABIOMED Competitive Intelligence
| Arrow International | CardiacAssist | Thoratec Corp | |
|---|---|---|---|
| Annual Sales ($ mil.) | 481.6 | 3.2 | 234.8 |
| Employees | 4,000 | 30 | 1,164 |
| Market Cap ($ mil.) | -- | -- | 909.5 |
Competitive Landscape
